18.07
-0.39 (-2.11%)
| Penutupan Terdahulu | 18.46 |
| Buka | 18.70 |
| Jumlah Dagangan | 1,370,373 |
| Purata Dagangan (3B) | 1,984,333 |
| Modal Pasaran | 5,770,317,824 |
| Harga / Pendapatan (P/E TTM) | 38.45 |
| Harga / Jualan (P/S) | 1.88 |
| Harga / Buku (P/B) | 172.86 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Oct 2026 |
| Margin Keuntungan | -0.46% |
| Margin Operasi (TTM) | 14.51% |
| EPS Cair (TTM) | -0.040 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5.50% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -49.70% |
| Nisbah Semasa (MRQ) | 1.40 |
| Aliran Tunai Operasi (OCF TTM) | 306.92 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 311.48 M |
| Pulangan Atas Aset (ROA TTM) | 6.67% |
| Pulangan Atas Ekuiti (ROE TTM) | -881.26% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Amneal Pharmaceuticals, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -1.0 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -1.75 |
|
Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 46.75% |
| % Dimiliki oleh Institusi | 43.76% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BUCHI J KEVIN | - | - | 0 | 0 |
| DALY JASON B. | - | 17.38 | -216,613 | -3,821,682 |
| PATEL CHINTU | 17.88 | - | 6,381,734 | 114,105,404 |
| PATEL CHIRAG K. | 17.88 | - | 6,381,734 | 114,105,404 |
| PATEL GAUTAM | 17.88 | - | 283,632 | 5,071,340 |
| PATEL TUSHAR BHIKHUBHAI | 17.88 | - | 12,763,469 | 228,210,826 |
| SHAH NIKITA | - | 17.66 | -146,403 | -2,585,477 |
| Jumlah Keseluruhan Kuantiti Bersih | 25,447,553 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 455,085,814 | |||
| Purata Pembelian Keseluruhan ($) | 17.88 | |||
| Purata Jualan Keseluruhan ($) | 17.47 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| DALY JASON B. | Pegawai | 12 Aug 2026 | Jual (-) | 210,000 | 17.66 | 3,708,600 |
| SHAH NIKITA | Pegawai | 12 Aug 2026 | Jual (-) | 146,403 | 17.66 | 2,585,477 |
| BUCHI J KEVIN | Pengarah | 11 Aug 2026 | Pelaksanaan pilihan | 168,573 | - | - |
| DALY JASON B. | Pegawai | 11 Aug 2026 | Jual (-) | 6,613 | 17.10 | 113,082 |
| PATEL CHIRAG K. | Pegawai | 10 Aug 2026 | Diperolehi (+) | 6,381,734 | 17.88 | 114,105,404 |
| PATEL GAUTAM | Pengarah | 10 Aug 2026 | Diperolehi (+) | 283,632 | 17.88 | 5,071,340 |
| PATEL CHINTU | Pegawai | 10 Aug 2026 | Diperolehi (+) | 6,381,734 | 17.88 | 114,105,404 |
| PATEL TUSHAR BHIKHUBHAI | 10 Aug 2026 | Diperolehi (+) | 12,763,469 | 17.88 | 228,210,826 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 29 Jun 2026 | CNBC | Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |